IRIS
MOLINELLI, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.854
AS - Asia 3.233
EU - Europa 3.008
SA - Sud America 686
AF - Africa 238
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.029
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.718
SG - Singapore 1.020
VN - Vietnam 771
CN - Cina 654
IT - Italia 629
RU - Federazione Russa 611
BR - Brasile 542
HK - Hong Kong 326
FR - Francia 273
IE - Irlanda 264
SE - Svezia 245
DE - Germania 231
UA - Ucraina 175
GB - Regno Unito 160
FI - Finlandia 148
IN - India 103
CI - Costa d'Avorio 100
CA - Canada 64
NL - Olanda 56
TR - Turchia 56
ZA - Sudafrica 55
BD - Bangladesh 54
AR - Argentina 51
MX - Messico 48
DK - Danimarca 46
JP - Giappone 42
MA - Marocco 42
IQ - Iraq 34
AT - Austria 32
ES - Italia 32
PL - Polonia 29
EC - Ecuador 27
ID - Indonesia 26
KR - Corea 25
UZ - Uzbekistan 19
BE - Belgio 18
VE - Venezuela 15
CL - Cile 14
CO - Colombia 14
PH - Filippine 14
PK - Pakistan 13
TH - Thailandia 12
LT - Lituania 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
EG - Egitto 8
GR - Grecia 8
JM - Giamaica 8
KE - Kenya 8
TN - Tunisia 8
MY - Malesia 7
PE - Perù 7
DZ - Algeria 6
NP - Nepal 6
AU - Australia 5
AZ - Azerbaigian 5
IL - Israele 5
PA - Panama 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
TW - Taiwan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CH - Svizzera 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EU - Europa 3
HR - Croazia 3
HU - Ungheria 3
JO - Giordania 3
KG - Kirghizistan 3
OM - Oman 3
PT - Portogallo 3
AL - Albania 2
GA - Gabon 2
GE - Georgia 2
KZ - Kazakistan 2
LY - Libia 2
QA - Qatar 2
RO - Romania 2
SM - San Marino 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LI - Liechtenstein 1
MD - Moldavia 1
ML - Mali 1
Totale 14.019
Salva come PNG Salva come JPEG
Città #
Ashburn 1.262
Singapore 662
Chandler 620
Dallas 493
San Jose 395
Des Moines 315
Hong Kong 315
Boardman 264
Ho Chi Minh City 257
Dublin 255
Fairfield 233
New York 203
Jacksonville 189
The Dalles 179
Hanoi 177
Council Bluffs 170
Los Angeles 146
Beijing 138
Seattle 119
Lauterbourg 114
Moscow 110
Wilmington 108
Abidjan 99
Houston 98
Munich 92
Woodbridge 91
Helsinki 89
Lawrence 82
Princeton 82
Cambridge 72
Ann Arbor 62
San Mateo 62
Ancona 59
Centro 57
Hefei 54
London 51
São Paulo 50
Da Nang 47
Chicago 46
Buffalo 44
Orem 41
Turin 41
San Diego 40
Haiphong 39
Turku 38
Washington 38
Johannesburg 37
Santa Clara 37
Pune 33
Shanghai 33
Rome 32
Tokyo 31
Guangzhou 29
Boydton 28
Brooklyn 28
Milan 28
Denver 25
Warsaw 25
Wuhan 25
Montreal 24
Chennai 23
Columbus 23
Nuremberg 23
San Francisco 21
Brussels 18
Amsterdam 17
Stockholm 17
Atlanta 16
Manchester 16
Urbisaglia 16
Vienna 16
Frankfurt am Main 15
Hải Dương 15
Tolentino 15
Elk Grove Village 14
Marche 14
Baghdad 13
Rio de Janeiro 13
Tashkent 13
Biên Hòa 12
Phoenix 12
Poplar 12
Salt Lake City 12
Boston 11
Curitiba 11
Porto Alegre 11
Toronto 11
Kazan' 10
Mexico City 10
Mumbai 10
Quito 10
Cape Town 9
Civitanova Marche 9
Guayaquil 9
Menlo Park 9
Ascoli Piceno 8
Brasília 8
Chaozhou 8
Charlotte 8
Dronten 8
Totale 9.139
Salva come PNG Salva come JPEG
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 318
Melanoma e tessuto adiposo peritumorale: studio preliminare sul ruolo delle adipocitochine nella caratterizzazione e prognosi di malattia 190
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 179
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 178
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 176
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 168
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 156
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 155
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 154
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 153
Involvement of the oral cavity in psoriasis: results of a clinical study 152
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 149
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 147
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 147
Oxidative stress and alterations of paraoxonases in atopic dermatitis 147
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 147
MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab 143
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 141
Biologic Therapy in Psoriasis: Safety Profile 140
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 138
Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa 137
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 137
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study 137
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 136
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 135
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 134
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 132
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 132
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 131
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 131
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 130
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 129
Review: A safety profile of dalbavancin for onand off-label utilization 129
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 127
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 126
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 125
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 124
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 124
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 123
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 123
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 123
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 121
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 121
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 121
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 120
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 120
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 120
Reticulated acanthoma with sebaceous differentiation 119
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 118
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 117
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 117
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 117
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 116
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 115
Relapsing acute generalized exanthematous pustolosis: a guess. 114
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 113
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 113
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 113
Biological treatments for pediatric psoriasis: state of the art and future perspectives 112
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 112
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 112
Topical application of fumaric acid esters improves appearance of nail psoriasis 112
Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review 111
Kaposi-Juliusberg varicelliform eruption in patient suffering from Darier-White disease: a case report and review of the literature 111
The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues 110
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 110
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 110
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 110
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 109
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 108
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 106
Mycosis Fungoides-like Eruption and Infliximab 106
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 106
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 105
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 104
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 103
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 103
Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study 102
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 102
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 101
Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: A controlled retrospective clinical study 100
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 99
The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience 99
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 99
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 97
Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi 97
Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma 96
CT patterns of interstitial lung disease in patients with plaque psoriasis: a retrospective case series study 96
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 96
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 94
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 94
Bimekizumab in hidradenitis suppurativa: a valid and rapid emerging treatment 93
Sneddon-Wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: Case report 92
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 91
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 90
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma 90
Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance 90
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 89
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 89
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 88
Totale 12.242
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.818
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021214 0 0 0 0 0 0 0 0 0 0 155 59
2021/2022692 16 100 27 12 29 46 25 53 47 28 137 172
2022/20231.897 132 187 122 176 114 474 8 103 381 10 130 60
2023/20241.281 160 24 150 135 165 293 27 71 19 85 16 136
2024/20252.399 315 179 75 37 99 98 234 94 499 168 316 285
2025/20266.593 561 409 548 694 739 489 1.364 599 581 596 13 0
Totale 14.384